William A Richards
Datos Biográficos
| ID | 1852589 |
|---|---|
| NOMBRE | William A Richards |
| NOMBRES | William A |
| APELLIDO | Richards |
| FIRMA | RICHARDS W A |
| AFILIACIONES | Johns Hopkins University |
| ORCID | 0000-0003-0730-9249 |
| VERIFICADO | Sí |
| TOTAL DE OBRAS | 15 |
| TOTAL DE CITAS | 24 |
| TOTAL COMO AUTOR | 15 |
| TOTAL COMO EDITOR | 0 |
| PRIMER AÑO DE PUBLICACIÓN | 1966 |
| AÑO MÁS RECIENTE DE PUBLICACIÓN | 2024 |
| ÍNDICE H | 2 |
Psychedelic Christianity
Development and Evaluation of a Therapist Training Program for Psilocybin Therapy for Treatment-Resistant Depression in Clinical Research
Introduction: Psychological support throughout psilocybin therapy is mandated by regulators as an essential part of ensuring participants' physical and psychological safety. There is an increased need for specially trained therapists who can provide high-quality care to participants in clinical studies. This paper describes the development and practical implementation of a therapist training program of psychological support within a current phase…
Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of pro…
Psilocybin can occasion mystical-type experiences with participant-attributed increases in well-being. However, little research has examined enduring changes in traits. This study administered psilocybin to participants who undertook a program of meditation/spiritual practices. Healthy participants were randomized to three groups (25 each): (1) very low-dose (1 mg/70 kg on sessions 1 and 2) with moderate-level (“standard”) support for spiritual-p…
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer
Cancer patients often develop chronic, clinically significant symptoms of depression and anxiety. Previous studies suggest that psilocybin may decrease depression and anxiety in cancer patients. The effects of psilocybin were studied in 51 cancer patients with life-threatening diagnoses and symptoms of depression and/or anxiety. This randomized, double-blind, cross-over trial investigated the effects of a very low (placebo-like) dose (1 or 3 mg/7…
Abraham Maslow’s Interest in Psychedelic Research
In this brief tribute to Abraham Maslow, a founder of the Journal of Humanistic Psychology, his interests in psychedelic research are described by the author who served as his research assistant from 1966 to 1967
Psychedelic Psychotherapy
Presented at a conference titled “Psychedelic Science 2013,” highlighting the resumption of investigations with psychedelic substances (i.e., psilocybin, DMT, LSD, MMDA, etc.) in the United States and Europe after a dormant period of more than two decades, the author presents insights and perspectives gleaned from his 25 years of clinical research experience. After acknowledging the vastness and potential significance of this research frontier, t…
Sacred knowledge
In the early 1960s, scientists openly advocated for experimentation with psychedelics. This effort, however, quickly turned into a discredited enterprise involving recreational drug use. But what if a study of psychedelics was undertaken with trusted scientific rigor? William A. Richards does just that in Sacred Knowledge, the first well-documented, sophisticated account of the effect of psychedelics on biological processes, human consciousness, …
Psilocybin occasioned mystical-type experiences
The Phenomenology and Potential Religious Import of States of Consciousness Facilitated by Psilocybin
Accompanying the resumption of human research with the entheogen (psychedelic drug), psilocybin, the range of states of consciousness reported during its action, including both nonmystical and mystical forms of experience, is surveyed and defined. The science and art of facilitating mystical experiences is discussed on the basis of research experience. The potential religious import of these states of consciousness is noted in terms of recognizin…
Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance
Entheogens in the Study of Religious Experiences
Effects of parental maltreatment on children's conceptions of interpersonal relationships
DPT as an Adjunct in Brief Psychotherapy with Cancer Patients
Thirty cancer patients suffering from psychological distress participated in a pilot project of individual psychotherapy that offered – over a four week period of time – approximately twelve hours of conventional verbal interaction and a single intensive drug-assisted therapy session that employed dipropyltryptamine (DPT), a short-acting psychedelic drug. The efficacy of the total therapeutic approach in enhancing the quality of life is indicated…
Mystical and archetypal experiences of terminal patients in DPT-assisted psychotherapy
Implications of LSD and experimental mysticism
Effects of parental maltreatment on children's conceptions of interpersonal relationships
Psychedelic Psychotherapy
Presented at a conference titled “Psychedelic Science 2013,” highlighting the resumption of investigations with psychedelic substances (i.e., psilocybin, DMT, LSD, MMDA, etc.) in the United States and Europe after a dormant period of more than two decades, the author presents insights and perspectives gleaned from his 25 years of clinical research experience. After acknowledging the vastness and potential significance of this research frontier, t…
Psychedelic Christianity
Abraham Maslow’s Interest in Psychedelic Research
In this brief tribute to Abraham Maslow, a founder of the Journal of Humanistic Psychology, his interests in psychedelic research are described by the author who served as his research assistant from 1966 to 1967
Implications of LSD and experimental mysticism
Mystical and archetypal experiences of terminal patients in DPT-assisted psychotherapy
DPT as an Adjunct in Brief Psychotherapy with Cancer Patients
Thirty cancer patients suffering from psychological distress participated in a pilot project of individual psychotherapy that offered – over a four week period of time – approximately twelve hours of conventional verbal interaction and a single intensive drug-assisted therapy session that employed dipropyltryptamine (DPT), a short-acting psychedelic drug. The efficacy of the total therapeutic approach in enhancing the quality of life is indicated…
Effects of parental maltreatment on children's conceptions of interpersonal relationships
Entheogens in the Study of Religious Experiences
Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance
The Phenomenology and Potential Religious Import of States of Consciousness Facilitated by Psilocybin
Accompanying the resumption of human research with the entheogen (psychedelic drug), psilocybin, the range of states of consciousness reported during its action, including both nonmystical and mystical forms of experience, is surveyed and defined. The science and art of facilitating mystical experiences is discussed on the basis of research experience. The potential religious import of these states of consciousness is noted in terms of recognizin…
Psilocybin occasioned mystical-type experiences
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer
Cancer patients often develop chronic, clinically significant symptoms of depression and anxiety. Previous studies suggest that psilocybin may decrease depression and anxiety in cancer patients. The effects of psilocybin were studied in 51 cancer patients with life-threatening diagnoses and symptoms of depression and/or anxiety. This randomized, double-blind, cross-over trial investigated the effects of a very low (placebo-like) dose (1 or 3 mg/7…
Abraham Maslow’s Interest in Psychedelic Research
In this brief tribute to Abraham Maslow, a founder of the Journal of Humanistic Psychology, his interests in psychedelic research are described by the author who served as his research assistant from 1966 to 1967
Psychedelic Psychotherapy
Presented at a conference titled “Psychedelic Science 2013,” highlighting the resumption of investigations with psychedelic substances (i.e., psilocybin, DMT, LSD, MMDA, etc.) in the United States and Europe after a dormant period of more than two decades, the author presents insights and perspectives gleaned from his 25 years of clinical research experience. After acknowledging the vastness and potential significance of this research frontier, t…
Sacred knowledge
In the early 1960s, scientists openly advocated for experimentation with psychedelics. This effort, however, quickly turned into a discredited enterprise involving recreational drug use. But what if a study of psychedelics was undertaken with trusted scientific rigor? William A. Richards does just that in Sacred Knowledge, the first well-documented, sophisticated account of the effect of psychedelics on biological processes, human consciousness, …
Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of pro…
Psilocybin can occasion mystical-type experiences with participant-attributed increases in well-being. However, little research has examined enduring changes in traits. This study administered psilocybin to participants who undertook a program of meditation/spiritual practices. Healthy participants were randomized to three groups (25 each): (1) very low-dose (1 mg/70 kg on sessions 1 and 2) with moderate-level (“standard”) support for spiritual-p…
Development and Evaluation of a Therapist Training Program for Psilocybin Therapy for Treatment-Resistant Depression in Clinical Research
Introduction: Psychological support throughout psilocybin therapy is mandated by regulators as an essential part of ensuring participants' physical and psychological safety. There is an increased need for specially trained therapists who can provide high-quality care to participants in clinical studies. This paper describes the development and practical implementation of a therapist training program of psychological support within a current phase…
Psychedelic Christianity
Psychology (15 obras) · Psychedelics and Drug Studies (11 obras) · Medicine (9 obras) · Psychiatry (8 obras) · Hallucinogen (7 obras) · Philosophy (7 obras) · Psilocybin (7 obras) · Psychoanalysis (6 obras) · Psychotherapist (6 obras) · Chemical synthesis and alkaloids (5 obras)